Literature DB >> 8113406

Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts.

S Garcia1, J H Nascimento, E Bonfa, R Levy, S F Oliveira, A V Tavares, A C de Carvalho.   

Abstract

In this study, IgG fractions from sera of SLE patients with anti-Ro/SSA or anti-Ro/SSA and anti-La/SSB activity were tested in Langendorff preparations of adult rabbit hearts, aiming to reproduce the cardiac manifestations observed in neonatal lupus in an experimental model. The hearts were perfused with normal Tyrode's solution for 30 min, followed by perfusion with Tyrode's containing 0.3 mg/ml of anti-Ro/SSA- (or anti-Ro/La-) positive IgG (nine sera), anti-ribonucleoprotein (RNP)-positive IgG (five sera), or IgG fractions from normal donors (five sera). In one third of the experiments done with anti-Ro/La-positive IgG, heart block was observed. With the remaining fractions, a decrease in heart rate of 17.1% was observed, but normal sinus rhythm was maintained. The IgG fractions with anti-RNP activity (five experiments) and from normal sera (six experiments) reduced heart rates by 12.9 and 3.3%, respectively, but heart block was not observed. To further characterize the cellular mechanisms involved in the conduction disturbances observed in the whole rabbit hearts, we conducted experiments with ventricular myocytes isolated from young rabbit hearts, studied by whole cell patch-clamp technique. In these experiments, the slow inward currents were analyzed during the superfusion of the cell with normal Tyrode's solution and 5 min after superfusion with Tyrode's solution containing 0.3 mg/ml of anti-Ro/SSA- (or anti-Ro/La-) positive IgG (five sera), anti-RNP-positive IgG (three sera), or IgG from normal donors (four sera). Resting and action potential amplitudes were not affected by any of the sera used. The anti-Ro/SSA IgG fraction induced a mean reduction in the peak slow inward current of 31.6%. IgG fractions with anti-RNP activity reduced slow inward current by 4.4%, whereas IgG fractions from normal donors increased this current by 3.3%. IgG-free fractions from sera of patients with anti-Ro/SSA activity did not alter the peak slow inward current. These results show, for the first time, that the presence of anti-Ro/SSA or anti-Ro/SSA and anti-La/SSB antibody activity in IgG fractions from lupus patients' sera can induce cardiac conduction disorders similar to those observed in neonatal lupus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8113406      PMCID: PMC293909          DOI: 10.1172/JCI117025

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis.

Authors:  N Kurata; E M Tan
Journal:  Arthritis Rheum       Date:  1976 May-Jun

2.  Fine specificities of autoantibodies directed against the Ro, La, Sm, RNP, and Jo-1 proteins defined by two-dimensional gel electrophoresis and immunoblotting.

Authors:  K B Elkon; P W Jankowski
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

3.  Congenital heart block in newborns of mothers with connective tissue disease.

Authors:  C M McCue; M E Mantakas; J B Tingelstad; S Ruddy
Journal:  Circulation       Date:  1977-07       Impact factor: 29.690

Review 4.  Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine.

Authors:  E M Tan
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

5.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

6.  Congenital heart block and maternal systemic lupus erythematosus.

Authors:  E Esscher; J S Scott
Journal:  Br Med J       Date:  1979-05-12

7.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

8.  Ro (SS-A) antibody and antigen in a patient with congenital complete heart block.

Authors:  J B Harley; J L Kaine; O F Fox; M Reichlin; B Gruber
Journal:  Arthritis Rheum       Date:  1985-12

9.  Anti-Ro/SS-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model. In vitro electrophysiologic and immunocytochemical studies.

Authors:  E Alexander; J P Buyon; T T Provost; T Guarnieri
Journal:  Arthritis Rheum       Date:  1992-02

10.  Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus.

Authors:  M D Lockshin; M L Druzin; S Goei; T Qamar; M S Magid; L Jovanovic; M Ferenc
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245

View more
  17 in total

Review 1.  Complete atrioventricular block in adult Sjögren's syndrome with anti-Ro autoantibody.

Authors:  Myung Jun Sung; Sung-Hoon Park; Seong-Kyu Kim; Young-Soo Lee; Chul-Yeon Park; Jung-Yoon Choe
Journal:  Korean J Intern Med       Date:  2011-06-01       Impact factor: 2.884

Review 2.  Neonatal lupus.

Authors:  Antonio Brucato; Rolando Cimaz; Marco Stramba-Badiale
Journal:  Clin Rev Allergy Immunol       Date:  2002-12       Impact factor: 8.667

3.  Defining a novel 75-kDa phosphoprotein associated with SS-A/Ro and identification of distinct human autoantibodies.

Authors:  D Wang; J P Buyon; W Zhu; E K Chan
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

Review 4.  Neonatal lupus: clinical features, therapy, and pathogenesis.

Authors:  L A Lee
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

5.  Identification and management of fetuses at risk for, or affected by, congenital heart block associated with autoantibodies to SSA (Ro), SSB (La), or an HsEg5-like autoantigen.

Authors:  Renate Claus; Heiko Hickstein; Thomas Külz; Ute Lenschow; Doris Meiske; Andrea Kotitschke; Hans-Jürgen Thiesen; Peter Lorenz
Journal:  Rheumatol Int       Date:  2006-01-10       Impact factor: 2.631

6.  Association of neutropenia in systemic lupus erythematosus (SLE) with anti-Ro and binding of an immunologically cross-reactive neutrophil membrane antigen.

Authors:  B T Kurien; J Newland; C Paczkowski; K L Moore; R H Scofield
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

Review 7.  Role of calcium channels in congenital heart block.

Authors:  E Karnabi; M Boutjdir
Journal:  Scand J Immunol       Date:  2010-09       Impact factor: 3.487

Review 8.  Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies.

Authors:  Antonio Brucato; Rolando Cimaz; Roberto Caporali; Véronique Ramoni; Jill Buyon
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

9.  Congenital heart block: identification of autoantibody binding site on the extracellular loop (domain I, S5-S6) of alpha(1D) L-type Ca channel.

Authors:  Eddy Karnabi; Yongxia Qu; Raj Wadgaonkar; Salvatore Mancarella; Yuankun Yue; Mohamed Chahine; Robert M Clancy; Jill P Buyon; Mohamed Boutjdir
Journal:  J Autoimmun       Date:  2009-07-28       Impact factor: 7.094

Review 10.  Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside.

Authors:  Jill P Buyon; Robert M Clancy; Deborah M Friedman
Journal:  Nat Clin Pract Rheumatol       Date:  2009-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.